(Q35817122)

10 August 2017

Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder (English)

1 reference

10 August 2017

Khaled El Gehani

1

1 reference

10 August 2017

Lamia Al-Kikhia

2

1 reference

10 August 2017

Fatma Emaetig

3

1 reference

10 August 2017

Kari Syrjänen

4

1 reference

10 August 2017

Omran Al-Fituri

5

1 reference

10 August 2017

Adam Elzagheid

6

1 reference

10 August 2017

language of work or name

1 reference

8 March 2012

1 reference

Libyan journal of medicine

10 August 2017

1 reference

10 August 2017

7

1 reference

Epidermal growth factor receptor expression in urinary bladder cancer

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Anti-HER agents in gastric cancer: from bench to bedside

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20 years' research.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

The present and future burden of urinary bladder cancer in the world

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

The global burden of urinary bladder cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Biology of HER2 and its importance in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

The ErbB signaling network: receptor heterodimerization in development and cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Prognostic value of amplification of c-erb-B2 in bladder carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Evaluation of epidermal growth factor receptors in bladder tumours

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Expression of c-erbB-2 gene product in urinary bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Use of Immunohistochemically Demonstrated c-erb B-2 Oncoprotein Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Urinary Bladder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Humanization of an anti-p185HER2 antibody for human cancer therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

27 July 2018

1 reference

https://api.crossref.org/works/10.3402%2FLJM.V7I0.14694

Molecular biology of bladder cancer: prognostic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3402%2FLJM.V7I0.14694

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3402%2FLJM.V7I0.14694

Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3402%2FLJM.V7I0.14694

Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3402%2FLJM.V7I0.14694

HER-2/neu in bladder carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Evaluation of HER2 protein overexpression in non-muscle-invasive bladder cancer with emphasis on tumour grade and recurrence

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Clinical significance of Her2/neu overexpression in urothelial carcinomas.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3298183

Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer

24 September 2018

1 reference

12 December 2020

The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy

1 reference

12 December 2020

Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2

1 reference

12 December 2020

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

12 December 2020

Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients

1 reference

12 December 2020

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications

1 reference

12 December 2020

Genetic alterations and biological pathways in human bladder cancer pathogenesis

1 reference

12 December 2020

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

1 reference

12 December 2020

Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis

1 reference

12 December 2020

Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors

1 reference

12 December 2020

HER2/neu expression in bladder cancer: relationship to cell cycle kinetics

1 reference

12 December 2020

HER-2--a possible target for therapy of metastatic urinary bladder carcinoma

1 reference

12 December 2020

Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer

1 reference

12 December 2020

C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value

1 reference

12 December 2020

Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder

1 reference

12 December 2020

Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance

1 reference

12 December 2020

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

12 December 2020

Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization

1 reference

12 December 2020

p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer

1 reference

12 December 2020

Identifiers

DOI

10.3402/LJM.V7I0.14694

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22408683

1 reference